What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 3 minute read Pharma Industry News Celltrion gains EC approval for Avtozma, a RoActemra biosimilar for autoimmune diseases Celltrion has received marketing authorization from the European Commission (EC) for Avtozma, a biosimilar to RoActemra (tocilizumab), expanding… byPallavi MadhirajuFebruary 24, 2025